X‐linked dominant protoporphyria: The first reported Japanese case
暂无分享,去创建一个
[1] R. Desnick,et al. X‐chromosomal inactivation directly influences the phenotypic manifestation of X‐linked protoporphyria , 2016, Clinical genetics.
[2] A. Anstey,et al. X‐linked dominant protoporphyria: a new porphyria , 2014, Clincal and Experimental Dermatology.
[3] J. Frank,et al. Photosensitivity in the elderly-think of late-onset protoporphyria. , 2013, The Journal of investigative dermatology.
[4] H. Bonkovsky,et al. Loss-of-Function Ferrochelatase and Gain-of-Function Erythroid-Specific 5-Aminolevulinate Synthase Mutations Causing Erythropoietic Protoporphyria and X-Linked Protoporphyria in North American Patients Reveal Novel Mutations and a High Prevalence of X-Linked Protoporphyria , 2013, Molecular Medicine.
[5] S. Ducamp,et al. Molecular and functional analysis of the C-terminal region of human erythroid-specific 5-aminolevulinic synthase associated with X-linked dominant protoporphyria (XLDPP). , 2013, Human molecular genetics.
[6] R. Desnick,et al. Molecular Expression and Characterization of Erythroid-Specific 5-Aminolevulinate Synthase Gain-of-Function Mutations Causing X-Linked Protoporphyria , 2013, Molecular Medicine.
[7] E. Neufeld,et al. Systematic molecular genetic analysis of congenital sideroblastic anemia: Evidence for genetic heterogeneity and identification of novel mutations , 2010, Pediatric blood & cancer.
[8] Joanne,et al. C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload. , 2008, American journal of human genetics.
[9] H. Willard,et al. X-inactivation profile reveals extensive variability in X-linked gene expression in females , 2005, Nature.
[10] S. Sassa,et al. Porphyrias in Japan: Compilation of All Cases Reported through 2002 , 2004, International journal of hematology.
[11] D. Reinberg,et al. Epigenetic Dynamics of Imprinted X Inactivation During Early Mouse Development , 2004, Science.